Skip to main content
OpenTrials
Completed

NCT Number: NCT01000363

Diabetes Group Visits

This pilot study aims to increase access to diabetes education by delivering it in a culturally-appropriate community setting and by involving different members of the diabetes care team including physicians, diabetes educators, and health promoters/community health workers.

Diabetes medical group visits will be held at the Grady North DeKalb satellite clinic the third Thursday of the month starting in October 2009. There will be two cohorts of patients- English speaking patients and Spanish speaking patients. Each group will be scheduled for 4 2-hour group visits throughout a period of 9 months. These visits will be every 8 weeks for each group. During the visit, the patient will be seen by a physician, attend a diabetes education session, re-fill their diabetes medications and receive lab orders.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Grady North DeKalb Clinic

Chamblee, Georgia, 30340, United States

About this study

Patients who participate in the diabetes group visits should achieve improvement in Clinical outcomes - better A1C levels, reduced blood pressure, reduced cholesterol levels ; adherence to evidence-based medicine - keeping appointments and scheduling eye exams, foot-checks, and/or taking medication as prescribed; behavioral outcomes- goal setting, achievement of goals, problem solving; access - attendance at educational sessions; ability to obtain affordable medications and devices; and satisfaction among patients and health professionals.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary care at the Grady North DeKalb Health center
  • Valid Grady card
  • Age 18-80
  • HbA1c>=8.0% - 11.0%
  • Must speak English or Spanish

Exclusion criteria

  • -Primary care provider excludes patient from study
  • Patient is reluctant to participate in a group visit
  • Reduced life expectancy as determined by any of the following:
  • End-stage renal disease on dialysis
  • Active congestive heart failure II and IV
  • Lung disease requiring supplemental oxygen
  • Current malignancy with any evidence of disease or currently undergoing chemotherapy or radiation therapy
  • Cirrhosis of the liver
  • AIDS
  • Mayor mental health disorders

Treatment and study plan

Primary outcomes

  1. Patients who participate in the diabetes group visits should achieve improvement in Clinical outcomes - better A1C levels, reduced blood pressure, reduced cholesterol levels

    Time frame: 1 year

Secondary outcomes

  1. keeping appointments and scheduling eye exams, foot checks

    Time frame: 1 year

  2. goal setting, achievement of goals, problem solving; access

    Time frame: 1 year

  3. attendance at educational sessions; and satisfaction among patients and health professionals

    Time frame: 1 year

  4. behavioral outcomes

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Emory University

Other

Collaborators

  • American Association of Diabetes Educators
  • Johnson & Johnson

Registry information

Official study title

Diabetes Medical Group Visits Pilot Study

Important dates

Study start
2009
Primary completion
2013
Study completion
2013
First posted
Oct 23, 2009
Registry last updated
Jul 9, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.